Innovation in Urine Collection Cuts Contamination, Retesting
Forte Medical (United Kingdom) characterizes traditional urine collection as a "start-stop-start-and-aim" endeavor that often devolves into a "hitand- miss process." To improve the quality and "dignity" of urine sample collection, the company has developed its Peezy Midstream device. The company’s cofounder found that contaminated urine samples resulted in high rates of repeat appointments and retests for patients presenting with suspected urinary tract infections (UTIs). Accurate diagnosis of UTIs, plus other conditions like prenatal and diabetes screenings, relies on midstream collection, but samples are frequently contaminated with first-void urine. With further investigation, Forte Medical determined contaminated urine samples are a costly problem throughout the U.K. health system. National contamination rates in the United Kingdom were estimated to be above 15 percent with each retest costing more than $13 U.S. Enter Peezy, a simple-to-use funnel engineered to capture midstream urine in a single, mess-free process. Peezy rejects first 8mL to 10mL of potentially contaminated urine. Urine causes expansion of compressed sponge, which blocks exit, causing midstream urine to be diverted into collection tube (30mL or 10mL). When this tube is full, excess urine exits through second, separate duct eliminating the possibility of funnel overflow. In addition to eliminating collection messes, spills, or […]
Subscribe to Clinical Diagnostics Insider to view
Start a Free Trial for immediate access to this article